Professor of Oncology Mikhail Blagosklonny, M.D. and PhD works at Roswell Park Cancer Institute in Buffalo, NY. He is also a prominent researcher in his fields and is well-known fin the medical community for hypothesising that the popular cacer-battling drug Rapamycin could have extensive benefits including anti-aging properties. His areas of focus are research of cancer and aging on botht the cellular and molecular planes. His mission is to truly understand normal cell cylces to best protect those in practical application of medicine to fight cancer cells and the effects of aging. His role as Editor-in-Chief of many medical journals including Oncotarget, Cell Cycle and Aging has provided him a wealth of knowledge in addition to his experience. His works have also been featured in the International Journal of Cancer and The American Journal of Pathology.